XAB2 tagSNPs contribute to non-small cell lung cancer susceptibility in Chinese population

BMC Cancer

Volumn 15, Issue 1, 2015, Pages

  Pei, Na ^a   Cao, Lei ^a   Liu, Yingwen ^a   Wu, Jing ^a   Song, Qinqin ^a   Zhang, Zhi ^a   Yuan, Juxiang ^a   Zhang, Xuemei ^a  

^a HEBEI UNITED UNIVERSITY   (China)

Author keywords

Lung cancer; Polymorphisms; Susceptibility; Transcriptional coupling nucleotide excision repair; XAB2

Indexed keywords

BINDING PROTEIN; UNCLASSIFIED DRUG; XPA BINDING PROTEIN 2; TRANSCRIPTION FACTOR; XAB2 PROTEIN, HUMAN;

ADULT; AGE; AGED; ALLELE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CHINESE; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON SMALL CELL LUNG CANCER; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; XAB2 GENE; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; CHINA; GENETIC PREDISPOSITION; GENETICS; LUNG TUMOR; PATHOLOGY;

ADULT; AGE FACTORS; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; CHINA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SEX FACTORS; TRANSCRIPTION FACTORS;

EID: 84938057925     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/s12885-015-1567-4     Document Type: Article

References (37)

1. Horak J, Sobota J, Burda J. Angiographic diagnostics of splenic tumours (author's transl). Cesk Radiol. 1975;29(5):348-55.
2. Bunn Jr PA. Worldwide overview of the current status of lung cancer diagnosis and treatment. Arch Pathol Lab Med. 2012;136(12):1478-81.
3. Kurkcuoglu N, Alaybeyi F. Topical capsaicin for psoriasis. Br J Dermatol. 1990;123(4):549-50.
4. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69-90.
5. Hecht SS. Lung carcinogenesis by tobacco smoke. Int J Cancer. 2012;131(12):2724-32.
6. Dresler C. The changing epidemic of lung cancer and occupational and environmental risk factors. Thorac Surg Clin. 2013;23(2):113-22.
7. Liu L, Wu J, Wu C, Wang Y, Zhong R, Zhang X, et al. A functional polymorphism (-1607 1G→2G) in the matrix metalloproteinase-1 promoter is associated with development and progression of lung cancer. Cancer. 2011;117(22):5172-81.
8. Ke J, Zhong R, Zhang T, Liu L, Rui R, Shen N, et al. Replication study in Chinese population and meta-analysis supports association of the 5p15.33 locus with lung cancer. PLoS One. 2013;8(4):e62485.
9. Yang IA, Holloway JW, Fong KM. Genetic susceptibility to lung cancer and co-morbidities. J Thorac Dis. 2013;5 Suppl 5:S454-62.
10. Scharer OD. Nucleotide excision repair in eukaryotes. Cold Spring Harb Perspect Biol. 2013;5(10):a012609.
11. Hanawalt PC, Spivak G. In: Dizdaroglu M, Karakaya AE, editors. Advances in DNA Damage and Repair. New York: Kluwer Academic/Plenum Publishers; 1999. p. 169-79.
12. Mellon I. Transcription-coupled repair: a complex affair. Mutat Res. 2005;577(1-2):155-61.
13. Hanawalt PC, Spivak G. Transcription-coupled DNA repair: two decades of progress and surprises. Nat Rev Mol Cell Biol. 2008;9(12):958-70.
14. van den Boom V, Jaspers NG, Vermeulen W. When machines get stuck--obstructed RNA polymerase II: displacement, degradation or suicide. Bioessays. 2002;24(9):780-4.
15. Leng S, Bernauer A, Stidley CA, Picchi MA, Sheng X, Frasco MA, et al. Association between common genetic variation in Cockayne syndrome A and B genes and nucleotide excision repair capacity among smokers. Cancer Epidemiol Biomarkers Prev. 2008;17(8):2062-9.
16. Lehmann AR. DNA repair-deficient diseases, xeroderma pigmentosum, Cockayne syndrome and trichothiodystrophy. Biochimie. 2003;85(11):1101-11.
17. Fousteri M, Mullenders LH. Transcription-coupled nucleotide excision repair in mammalian cells: molecular mechanisms and biological effects. Cell Res. 2008;18(1):73-84.
18. Reddy JK, Rao S, Moody DE. Hepatocellular carcinomas in acatalasemic mice treated with nafenopin, a hypolipidemic peroxisome proliferator. Cancer Res. 1976;36(4):1211-7.
19. Kuraoka I, Ito S, Wada T, Hayashida M, Lee L, Saijo M, et al. Isolation of XAB2 complex involved in pre-mRNA splicing, transcription, and transcription-coupled repair. J Biol Chem. 2008;283(2):940-50.
20. Nakatsu Y, Asahina H, Citterio E, Rademakers S, Vermeulen W, Kamiuchi S, et al. XAB2, a novel tetratricopeptide repeat protein involved in transcription-coupled DNA repair and transcription. J Biol Chem. 2000;275(45):34931-7.
21. Yu X, Rao J, Lin J, Zhang Z, Cao L, Zhang X. Tag SNPs in complement receptor-1 contribute to the susceptibility to non-small cell lung cancer. Mol Cancer. 2014;13:56.
22. Dreij K, Seidel A, Jernstrom B. Differential removal of DNA adducts derived from anti-diol epoxides of dibenzo[a, l]pyrene and benzo[a]pyrene in human cells. Chem Res Toxicol. 2005;18(4):655-64.
23. Lage C, de Padula M, de Alencar TA, da Fonseca Goncalves SR, da Silva VL, Cabral-Neto J, et al. New insights on how nucleotide excision repair could remove DNA adducts induced by chemotherapeutic agents and psoralens plus UV-A (PUVA) in Escherichia coli cells. Mutat Res. 2003;544(2-3):143-57.
24. Hollander MC, Philburn RT, Patterson AD, Velasco-Miguel S, Friedberg EC, Linnoila RI, et al. Deletion of XPC leads to lung tumors in mice and is associated with early events in human lung carcinogenesis. Proc Natl Acad Sci U S A. 2005;102(37):13200-5.
25. Melis JP, Wijnhoven SW, Beems RB, Roodbergen M, van den Berg J, Moon H, et al. Mouse models for xeroderma pigmentosum group A and group C show divergent cancer phenotypes. Cancer Res. 2008;68(5):1347-53.
26. van der Horst GT, van Steeg H, Berg RJ, van Gool AJ, de Wit J, Weeda G, et al. Defective transcription-coupled repair in Cockayne syndrome B mice is associated with skin cancer predisposition. Cell. 1997;89(3):425-35.
27. Cheng L, Spitz MR, Hong WK, Wei Q. Reduced expression levels of nucleotide excision repair genes in lung cancer: a case-control analysis. Carcinogenesis. 2000;21(8):1527-30.
28. Ohnuma-Ishikawa K, Morio T, Yamada T, Sugawara Y, Ono M, Nagasawa M, et al. Knockdown of XAB2 enhances all-trans retinoic acid-induced cellular differentiation in all-trans retinoic acid-sensitive and -resistant cancer cells. Cancer Res. 2007;67(3):1019-29.
29. Briggs FB, Goldstein BA, McCauley JL, Zuvich RL, De Jager PL, Rioux JD, et al. Variation within DNA repair pathway genes and risk of multiple sclerosis. Am J Epidemiol. 2010;172(2):217-24.
30. Kim JG, Chae YS, Sohn SK, Moon JH, Kang BW, Park JY, et al. IVS10 + 12A > G polymorphism in hMSH2 gene associated with prognosis for patients with colorectal cancer. Ann Oncol. 2010;21(3):525-9.
31. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Personal habits and indoor combustions. Volume 100 E. A review of human carcinogens. IARC Monogr Eval Carcinog Risks Hum. 2012;100(Pt E)):1-538.
32. de Groot P, Munden RF. Lung cancer epidemiology, risk factors, and prevention. Radiol Clin North Am. 2012;50(5):863-76.
33. Schwartz AG, Prysak GM, Bock CH, Cote ML. The molecular epidemiology of lung cancer. Carcinogenesis. 2007;28(3):507-18.
34. Jassem E, Szymanowska A, Sieminska A, Jassem J. Smoking and lung cancer. Pneumonol Alergol Pol. 2009;77(5):469-73.
35. Stern MC, Umbach DM, van Gils CH, Lunn RM, Taylor JA. DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev. 2001;10(2):125-31.
36. Letkova L, Matakova T, Musak L, Sarlinova M, Krutakova M, Slovakova P, et al. DNA repair genes polymorphism and lung cancer risk with the emphasis to sex differences. Mol Biol Rep. 2013;40(9):5261-73.
37. Gauderman WJ, Morrison JL. Evidence for age-specific genetic relative risks in lung cancer. Am J Epidemiol. 2000;151(1):41-9.